Concepedia

Publication | Open Access

Rationale for an adjunctive therapy with fenofibrate in pharmacoresistant nocturnal frontal lobe epilepsy

41

Citations

30

References

2017

Year

Abstract

Our preclinical and clinical studies suggest PPARα as a novel disease-modifying target for antiepileptic drugs due to its ability to regulate dysfunctional nAChRs.

References

YearCitations

Page 1